(1)  This regulation applies to the following substances:

(a) acitretin for human use;

(b) alefacept for human use;

(c) ambrisentan for human use;

(d) bexarotene for human use;

(e) bosentan for human use;

(f) cannabidiol;

(g) clomiphene for human use;

(h) corifollitropin alfa (recombinant follicle stimulant) for human use;

(i) cyclofenil for human use;

(j) dinoprost for human use;

(k) dinoprostone;

(l) dronabinol (S8);

(m) etretinate for human use;

(n) follitropin alpha (recombinant human follicle-stimulating hormone) for human use;

(o) follitropin beta (recombinant human follicle-stimulating hormone) for human use;

(p) isotretinoin for human oral use;

(q) lenalidomide;

(r) luteinising hormone (S4) for human use;

(s) macitentan for human use;

(t) riociguat for human use;

(u) sitaxentan for human use;

(v) teriparatide for human use;

(w) thalidomide for human use;

(x) tretinoin for human oral use;

(y) urifollitropin (otherwise known as follicle-stimulating hormone) for human use.

(2)  Subject to subregulation (3) , a person must not prescribe, sell or supply a substance to which this regulation applies for human use unless that person is –

(a) authorised by the Secretary to do so; or

(b) included in a class of persons authorised by the Secretary to do so.

Penalty:  Fine not exceeding 10 penalty units.

(3)  Subregulation (2) does not apply to the sale or supply of any substance specified in that subregulation –

(a) by a wholesale chemist in the ordinary course of wholesale dealing; or

(b) by a pharmaceutical chemist on the prescription of a person who has the authority of the Secretary to prescribe the substance.

(4)  A person authorised under this regulation to prescribe or supply any of the substances specified in this regulation must comply with such conditions as are specified in the authority.

Penalty:  Fine not exceeding 10 penalty units.

(5)  The Secretary may at any time revoke an authority given under this regulation.